Advertisement
Canada markets open in 1 hour 25 minutes
  • S&P/TSX

    22,265.05
    -108.35 (-0.48%)
     
  • S&P 500

    5,306.04
    +1.32 (+0.02%)
     
  • DOW

    38,852.86
    -216.74 (-0.55%)
     
  • CAD/USD

    0.7315
    -0.0022 (-0.29%)
     
  • CRUDE OIL

    80.43
    +0.60 (+0.75%)
     
  • Bitcoin CAD

    92,583.66
    -708.34 (-0.76%)
     
  • CMC Crypto 200

    1,463.46
    -21.24 (-1.43%)
     
  • GOLD FUTURES

    2,340.40
    -16.10 (-0.68%)
     
  • RUSSELL 2000

    2,066.85
    -2.82 (-0.14%)
     
  • 10-Yr Bond

    4.5420
    +0.0750 (+1.68%)
     
  • NASDAQ futures

    18,817.75
    -122.75 (-0.65%)
     
  • VOLATILITY

    13.96
    +1.04 (+8.06%)
     
  • FTSE

    8,222.70
    -31.48 (-0.38%)
     
  • NIKKEI 225

    38,556.87
    -298.50 (-0.77%)
     
  • CAD/EUR

    0.6737
    -0.0015 (-0.22%)
     

Stocks in play: Oncolytics Biotech Inc

Announced it has entered into a preliminary collaboration with the Global Coalition for Adaptive Research. The purpose of the preliminary collaboration is to commence planning activities for the evaluation of pelareorep in the treatment of first-line metastatic pancreatic ductal adenocarcinoma as part of GCAR's anticipated master protocol for metastatic pancreatic cancer. Activities are currently underway to finalize the seamless Phase 2/3 master protocol design that will evaluate multiple investigational therapies for the treatment of pancreatic cancer. An intent of the study is to produce registration-enabling data. Oncolytics Biotech Inc shares T.ONC are trading up $0.02 at $1.62.

Read: